ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 116 filers reported holding ENZO BIOCHEM INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $734,000 | +21.7% | 203,962 | +14.0% | 0.19% | +32.0% |
| Q2 2019 | $603,000 | -73.1% | 178,939 | -16.4% | 0.15% | -50.7% |
| Q3 2017 | $2,242,000 | +27.0% | 214,155 | +33.9% | 0.30% | +2.1% |
| Q2 2017 | $1,766,000 | +27.1% | 159,930 | -3.7% | 0.29% | +33.3% |
| Q1 2017 | $1,390,000 | -22.9% | 166,057 | -36.1% | 0.22% | -8.8% |
| Q4 2016 | $1,804,000 | +32.5% | 259,914 | -2.8% | 0.24% | +31.1% |
| Q3 2016 | $1,361,000 | -14.7% | 267,368 | 0.0% | 0.18% | -23.8% |
| Q2 2016 | $1,596,000 | -54.8% | 267,368 | -61.0% | 0.24% | -66.6% |
| Q3 2014 | $3,532,000 | -1.9% | 685,903 | 0.0% | 0.72% | +5.1% |
| Q2 2014 | $3,601,000 | +68.0% | 685,903 | +33.1% | 0.68% | +76.9% |
| Q1 2014 | $2,143,000 | – | 515,191 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |